Chronotherapy With Low-Dose Aspirin for Prevention of Complications in Pregnancy

REFERENCES

• Angeli A, Gatti G, Masera R. (1992). Chronobiology of the hypothalamic-pituitary-adrenal and renin-angiotensin-aldosterone systems. In Touitou Y, Haus E (Eds.). Biologic rhythms in clinical and laboratory medicine. Berlin: Springer-Verlag, 292–314.
   Google Scholar
• Antiplatelet Trialists' Collaboration. (1994). Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308:81–106.
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists' Collaboration. (2002). Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71–86.
   PubMed Web of Science ®Google Scholar
• Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARIS Collaborative Group. (2007). Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369:1791e–1798e.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC. (2001). Influence of parity and age on ambulatory monitored blood pressure during pregnancy. Hypertension 38:753–758.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC. (2010). Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects. Chronobiol. Int. 27:345–362.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC. (2012). Ambulatory blood pressure monitoring for the early identification of hypertension in pregnancy. Chronobiol. Int. 29: 233–259.
   Google Scholar
• Ayala DE, Hermida RC, Mojón A, Fernández JR, Iglesias M. (1997a). Circadian blood pressure variability in healthy and complicated pregnancies. Hypertension 30:603–610.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC, Mojón A, Fernández JR, Silva I, Ucieda R, Iglesias M. (1997b). Blood pressure variability during gestation in healthy and complicated pregnancies. Hypertension 30:611–618.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC, Mojón A, Fernández JR. (2013a). Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol. Int. 30: 340–352.
   Web of Science ®Google Scholar
• Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, Sineiro E, Mojón A, Fontao MJ, Hermida RC, on behalf of the Hygia Project Investigators. (2013b). Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol. Int. 30: 99–115.
   Web of Science ®Google Scholar
• Barth W. (1998). Low-dose aspirin for preeclampsia. The unresolved question. N. Engl. J. Med. 338:756–757.
   PubMed Web of Science ®Google Scholar
• Bartter FC, Chan JCM, Simpson HW. (1979). Chronobiological aspect of plasma renin activity, plasma aldosterone and urinary electrolytes. In Krieger DT (Ed.). Endocrine rhythms. New York: Raven, 49–132.
   Google Scholar
• Beaufils M, Uzan S, Donsimoni R, Colau JC. (1985). Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1:840–842.
   PubMed Web of Science ®Google Scholar
• Benedetto C, Zonca M, Marozio L, Dolco C, Carandente F, Massobrio M. (1996). Blood pressure patterns in normal pregnancy and in pregnancy-induced hypertension, preeclampsia, and chronic hypertension. Obstet. Gynecol. 88:503–510.
   PubMed Web of Science ®Google Scholar
• Bingham C, Arbogast B, Cornélissen G, Lee JK, Halberg F. (1982). Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia 9:397–439.
   PubMedGoogle Scholar
• Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. (2001). The classification and diagnosis of the hypertensive disorders of pregnancy: statement from The International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens. Pregnancy 20:ix–xiv.
   Web of Science ®Google Scholar
• Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD, Klebanoff M, Vandorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G, National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. (2002). Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild pre-eclampsia. Am. J. Obstet. Gynecol. 186:66–71.
   PubMed Web of Science ®Google Scholar
• Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC, Giguère Y. (2009). Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J. Obstet. Gynaecol. Can. 31:818–826.
   PubMedGoogle Scholar
• Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y. (2010). Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet. Gynecol. 116:402–414.
   PubMed Web of Science ®Google Scholar
• Bujold E, Tapp S, Audibert F, Ferreira E, Forest JC, Rey E, Fraser WD, Chaillet N, Giguère Y. (2011). Prevention of adverse pregnancy outcomes with low-dose ASA in early pregnancy: new perspectives for future randomized trials. J. Obstet. Gynaecol. Can. 33:480–483.
   PubMedGoogle Scholar
• Bussolino F, Benedetto C, Massobrio M, Camussi G. (1980). Maternal vascular prostacyclin activity in pre-eclampsia. Lancet 2:702.
   PubMed Web of Science ®Google Scholar
• Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G. (1998). Low-dose aspirin to prevent preeclampsia in women at high risk. N. Engl. J. Med. 338:701–705.
   PubMed Web of Science ®Google Scholar
• CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. (1994). CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 343:619–629.
   PubMed Web of Science ®Google Scholar
• Cornélissen G, Halberg F, Prikryl P, Dankova E, Siegelova J, Dusek J, International Womb-To-Tomb Chronome Study Group. (1991). Prophylactic aspirin treatment: the merits of timing. JAMA 266:3128–3129.
   PubMed Web of Science ®Google Scholar
• Cugini P, Manconi E, Serdoz N, Mancini A, Meucci R, Scavo D. (1980). Rhythm characteristics of plasma renin, aldosterone and cortisol in five types of mesor-hypertension. J. Endocrinol. Invest. 3:143–149.
   PubMed Web of Science ®Google Scholar
• Cugini P, Letizia C, Scavo D. (1988). The circadian rhythmicity of serum angiotensin converting enzyme: its phasic relation with the circadian cycle of plasma renin and aldosterone. Chronobiologia 15:229–232.
   PubMedGoogle Scholar
• Dekker GA, Sibai BM. (1993). Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials. Am. J. Obstet. Gynecol. 168:214–227.
   PubMed Web of Science ®Google Scholar
• Delemarre FM, Didden MA, de Jong PA. (1996). Diurnal variation in angiotensin sensitivity in pregnancy. Am. J. Obstet. Gynecol. 174:259–261.
   PubMed Web of Science ®Google Scholar
• Duguay D, Cermakian N. (2009). The crosstalk between physiology and circadian clock proteins. Chronobiol. Int. 26:1479–1513.
   PubMed Web of Science ®Google Scholar
• Duley L. (2009). The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 33:130–137.
   PubMed Web of Science ®Google Scholar
• Dumont A, Flahault A, Beaufils M, Verdy E, Uzan S. (1999). Effect of aspirin in pregnant women is dependent on increase in bleeding time. Am. J. Obstet. Gynecol. 180:135–140.
   PubMed Web of Science ®Google Scholar
• ECPPA (Estudo Colaborativo para Prevençao da Pré-eclampsia com Aspirina) Collaborative Group. (1996). ECPPA: a randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br. J. Obstet. Gynaecol. 103:39–47.
   Google Scholar
• Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi F. (2013). Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol. Int. 30: 17–30.
   Web of Science ®Google Scholar
• Fernández JR, Hermida RC. (1998). Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol. Int. 15:191–204.
   PubMed Web of Science ®Google Scholar
• Fernández JR, Mojón A, Hermida RC, Alonso I. (2003). Methods for comparison of parameters from longitudinal rhythmometric models with multiple components. Chronobiol. Int. 20:495–513.
   PubMed Web of Science ®Google Scholar
• Friedman SA. (1988). Preeclampsia: a review of the role of prostaglandins. Obstet. Gynecol. 71:122–137.
   PubMed Web of Science ®Google Scholar
• Fuster V, Dyken ML, Vokonas PS, Hennekens C. (1993). Aspirin as a therapeutic agent in cardiovascular disease. Circulation 87:659–675.
   PubMed Web of Science ®Google Scholar
• Gallerani M, Portaluppi F, Grandi E, Manfredini R. (1997). Circadian rhythmicity in the occurrence of spontaneous acute dissection and rupture of thoracic aorta. J. Thorac. Cardiovasc. Surg. 113:603–604.
   PubMed Web of Science ®Google Scholar
• Golding J. A randomised trial of low dose aspirin for primiparae in pregnancy. (1998). Br. J. Obstet. Gynaecol. 105:293–299.
   PubMedGoogle Scholar
• Gordon RD, Wolfe LK, Island DP, Liddle GW. (1966). A diurnal rhythm in plasma renin activity in man. J. Clin. Invest. 45:1587–1592.
   PubMed Web of Science ®Google Scholar
• Grosser N, Schroder H. (2003). Aspirin protects endothelial cells from oxidant damage via the nitric-oxide-cGMP pathway. Arterioscler. Thromb. Vasc. Biol. 23:1345–1351.
   PubMed Web of Science ®Google Scholar
• Haus E, Cusulos M, Sackett-Lundeen L, Swoyer J. (1990). Circadian variations in platelet functions and blood coagulation parameters. In Reinberg A, Smolensky M, Labrecque G (Eds.). Annual review of chronopharmacology, Vol. 7. Oxford, UK: Pergamon Press, pp. 153–156.
   Google Scholar
• Hayden M, Pignone M, Phillips C, Mulrow C. (2002). Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 136:161–171.
   PubMed Web of Science ®Google Scholar
• Hermida RC. (1999). Time-qualified reference values for 24 h ambulatory blood pressure monitoring. Blood Press. Monit. 4:137–147.
   PubMedGoogle Scholar
• Hermida RC, Ayala DE. (1997). Diagnosing gestational hypertension and preeclampsia with the 24-hour mean of blood pressure. Hypertension 30:1531–1537.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. (2001). Evaluation of the blood pressure load in the diagnosis of hypertension in pregnancy. Hypertension 38:723–729.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. (2002). Prognostic value of office and ambulatory blood pressure measurements in pregnancy. Hypertension 40:298–303.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. (2003). Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy. Hypertension 42:619–624.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. (2004). Prognostic value of ambulatory blood pressure measurements for the diagnosis of hypertension in pregnancy. Expert Rev. Cardiovasc. Ther. 2:89–105.
   PubMedGoogle Scholar
• Hermida RC, Ayala DE. (2005a). Reference thresholds for 24-hour, diurnal, and nocturnal blood pressure mean values in pregnancy. Blood Press. Monit. 10:33–41.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. (2005b). Circadian blood pressure variability in normotensive pregnant women as a function of parity, maternal age, and stage of gestation. Chronobiol. Int. 22:321–341.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. (2009). Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension 54:40–46.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR. (1996). Computation of time-specified tolerance intervals for ambulatorily monitored blood pressure. Biomed. Instrum. Technol. 30:257–266.
   PubMedGoogle Scholar
• Hermida RC, Smolensky MH. (2004). Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens. 13:501–505.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR, Ayala DE. (1996). Computer-based medical system for the computation of blood pressure excess in the diagnosis of hypertension. Biomed. Instrum. Technol. 30:267–283.
   PubMedGoogle Scholar
• Hermida RC, Ayala DE, Iglesias M, Mojón A, Silva I, Ucieda R, Fernández JR. (1997a). Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension 30:589–595.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR, Ayala DE, Mojón A, Iglesias M. (1997b). Influence of aspirin usage on blood pressure. Dose and administration time-dependencies. Chronobiol. Int. 14:619–637.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR, Ayala DE. (1997c). The tolerance-hyperbaric test for hypertension diagnosis. Biomed. Instrum. Technol. 31:499–510.
   PubMedGoogle Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR, Silva I, Ucieda R, Iglesias M. (1998). Blood pressure excess for the early identification of gestational hypertension and preeclampsia. Hypertension 31:83–89.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Silva I, Ucieda R, Codesido J, Iglesias M. (1999). Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. Hypertension 34:1016–1023.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR, Alonso I, Silva I, Ucieda R, Iglesias M. (2000a). Blood pressure patterns in normal pregnancy, gestational hypertension and preeclampsia. Hypertension 36:149–158.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR, Mojón A, Ayala DE. (2000b). Reproducibility of the hyperbaric index as a measure of blood pressure excess. Hypertension 35:118–125.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M. (2001a). Predictable blood pressure variability in healthy and complicated pregnancies. Hypertension 38:736–741.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2001b). Time-qualified reference values for ambulatory blood pressure monitoring in pregnancy. Hypertension 38:746–752.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Calvo C. (2002a). Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol. Int. 19:461–481.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Fernández JR, Ruilope LM, López JE. (2002b). Evaluation of the extent and duration of the “ABPM effect” in hypertensive patients. J. Am. Coll. Cardiol. 40:710–717.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. (2002c). Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 20:1097–1104.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR, Alonso I, Ayala DE. (2002d). The tolerance-hyperbaric test: a chronobiologic approach for improved diagnosis of hypertension. Chronobiol. Int. 19:1183–1211.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, López JE, Fernández JR, Mojón A, Domínguez MJ, Covelo M. (2003a). Administration-time dependent effects of aspirin on blood pressure in untreated hypertensive patients. Hypertension 41:1259–1267.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M. (2003b). Circadian rhythm of blood pressure challengues office values as the “gold standard” in the diagnosis of gestational hypertension. Chronobiol. Int. 20:135–156.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M. (2003c). Administration-time dependent influence of aspirin on blood pressure in pregnant women. Hypertension 41:651–656.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR, Alonso I, Aguilar MF, Ucieda R, Iglesias M. (2003d). Differences in circadian blood pressure variability during gestation between healthy and complicated pregnancies. Am. J. Hypertens. 16:200–208.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Mojón A, López JE. (2003e). Administration-time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 42:283–290.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M. (2004a). Differences in circadian pattern of ambulatory pulse pressure between healthy and complicated pregnancies. Hypertension 44:316–321.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M. (2004b). Circadian blood pressure variability as a function of parity in normotensive pregnant women. J. Clin. Hypertens. 6:126–133.
   Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A, Iglesias M. (2004c). Reproducibility of the tolerance-hyperbaric test for diagnosing hypertension in pregnancy. J. Hypertens. 22:565–572.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Fontao MJ, López JE. (2004d). Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol. Int. 21:277–296.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR, Ayala DE, Mojón A, Alonso I, Calvo C. (2004e). Circadian time-qualified tolerance intervals for ambulatory blood pressure monitoring in the diagnosis of hypertension. Chronobiol. Int. 21:149–170.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, López JE. (2005a). Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients. J. Am. Coll. Cardiol. 46:975–983.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, López JE, Mojón A, Rodríguez M, Fernández JR. (2005b). Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. Hypertension 46:1060–1068.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Calvo C. (2007a). Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 50:715–722.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. Fernandez JR, Mojón A, Calvo C. (2007b). Influence of measurement duration and frequency on ambulatory blood pressure monitoring. Rev. Esp. Cardiol. 60:131–138.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Portaluppi F. (2007c). Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv. Drug Deliv. Rev. 59:904–922.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. (2007d). Chronotherapy of hypertension: administration-time dependent effects of treatment on the circadian pattern of blood pressure. Adv. Drug Deliv. Rev. 59:923–939.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Chayán L, Mojón A, Fernández JR. (2009a). Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol. Int. 26:61–79.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2009b). Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. Am. J. Hypertens. 22:896–903.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Alonso I, Fernández JR. (2010a). Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol. Int. 27:560–574.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. (2010b). Chronotherapy with valsartan/amlodipine combination in essential hypertension: improved blood pressure control with bedtime dosing. Chronobiol. Int. 27:1287–1303.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010c). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol. Int. 27:1629–1651.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. (2011a). Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am. J. Hypertens. 24:383–391.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011b). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J. Am. Coll. Cardiol. 58:1165–1173.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011c). Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34:1270–1276.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011d). Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J. Am. Soc. Nephrol. 22:2313–2321.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fontao MJ, Fernández JR. (2011e). Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Chronobiol. Int. 28:601–610.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012a). Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Am. J. Hypertens. 25:297–305.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012b). Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am. J. Hypertens. 25:325–334.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013a). Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol. Int. 30: 68–86.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. (2013b). Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol. Int. 30: 280–314.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. (2013c). Ambulatory blood pressure monitoring: importance of sampling rate and duration—48 versus 24 hours—on the accurate assessment of cardiovascular risk. Chronobiol. Int. 30: 55–67.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013d). Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level—the “normotensive non-dipper” paradox. Chronobiol Int. 30: 87–98.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013e). Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol. Int. 30: 315–327.
   Web of Science ®Google Scholar
• Hernández-Díaz S, Toh S, Cnattingius S. (2009). Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ 338:b2255.
   PubMed Web of Science ®Google Scholar
• Higashi Y, Nakagawa K, Kimura M, Noma K, Hara K, Sasaki S, Goto C, Oshima T, Chayama K, Yoshizumi M. (2002). Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J. Am. Coll. Cardiol. 40:2039–2043.
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Petrulis A. (1991). A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 266:261–265.
   Web of Science ®Google Scholar
• Italian Study of Aspirin in Pregnancy. (1993). Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet 341:396–400.
   PubMed Web of Science ®Google Scholar
• Janes SL, Kyle PM, Redman C, Goodall AH. (1995). Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thromb. Haemost. 74:1059–1063.
   PubMed Web of Science ®Google Scholar
• Johnson AG, Nguyen TV, Day RO. (1994). Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann. Intern. Med. 121:289–300.
   PubMed Web of Science ®Google Scholar
• Kanabrocki EL, George M, Hermida RC, Messmore HL, Ryan MD, Ayala DE, Hoppensteadt DA, Fareed J, Bremmer FW, Third JLHC, Shirazi P, Nemchausky BA. (2001). Day-night variations in blood levels of nitric oxide, T-TFPI and E-selectin. Clin. Appl. Thromb. Hemostasis 7:339–345.
   PubMed Web of Science ®Google Scholar
• Kanzik I, Cakici I, Ersoy S, Ark M, Abacioglu N, Zengil H. (1992). Effects of cyclooxygenase and lipoxygenase inhibitors on digoxin-induced arrhythmias and haemodynamics in guinea-pigs. Pharmacol. Res. 26:305–316.
   PubMed Web of Science ®Google Scholar
• Katz F, Romfh P, Smith JA. (1975). Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man. J. Clin. Endocrinol. Metab. 40:125–134.
   PubMed Web of Science ®Google Scholar
• Khan KS, Wojdyla D, Say L, Gulmezoglu Am, Van Look PF. (2006). WHO analysis of causes of maternal death: a systematic review. Lancet 367:1066–1074.
   PubMed Web of Science ®Google Scholar
• Klemmensen AK, Olsen SF, Osterdal ML, Tabor A. (2007). Validity of pre-eclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. Am. J. Epidemiol. 166:117–124.
   PubMed Web of Science ®Google Scholar
• Labrecque G, Reinberg A. (1989). Chronopharmacology of nonsteroid anti-inflammatory drugs. In Lemmer B (Ed.). Chronopharmacology: cellular and biochemical interactions. New York: Marcel Dekker, 545–579.
   Google Scholar
• Lawler J, Osman M, Shelton JA, Yeh J. (2007). Population-based analysis of hypertensive disorders in pregnancy. Hypertens. Pregnancy 26:67–76.
   PubMed Web of Science ®Google Scholar
• Leitich H, Egarter C, Husslein P, Kaider A, Schemper M. (1997). A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br. J. Obstet. Gynecol. 104:450–459.
   PubMedGoogle Scholar
• Manfredini R, Gallerani M, Portaluppi F, Fersini C. (1996). Relationships of the circadian rhythms of thrombotic, ischemic, hemorrhagic, and arrhythmic events to blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:141–158.
   PubMed Web of Science ®Google Scholar
• Manson JE, Stampfer MJ, Colditz GA, Willet WC, Rosner B, Speizer FE, Hennekens CH. (1991). A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 266:521–527.
   PubMed Web of Science ®Google Scholar
• Marín R, Gorostidi M, Portal CG, Sánchez M, Sánchez E, Alvarez J. (2000). Long-term prognosis of hypertension in pregnancy. Hypertens. Pregnancy 19:199–209.
   PubMed Web of Science ®Google Scholar
• Markiewicz A, Semenowicz K. (1979). Time dependent changes in the pharmacokinetics of aspirin. Int. J. Clin. Pharmacol. Biopharm. 17:409–411.
   PubMedGoogle Scholar
• Masotti G, Galanti G, Poggesi L, Abbate R, Neri Serneri GG. (1979). Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet 2:1213–1217.
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Shimokawa H, Sumioki H, Touno A, Nakano H. (1998). Circadian rhythm of plasma atrial natriuretic peptide, aldosterone, and blood pressure during the third trimester in normal and preeclamptic pregnancy. Am. J. Obstet. Gynecol. 158:393–399.
   Google Scholar
• Moore JG, Goo RH. (1987). Day and night aspirin-induced gastric mucosal damage and protection by ranitidine in man. Chronobiol. Int. 4:111–116.
   PubMed Web of Science ®Google Scholar
• Page NM. (2002). The endocrinology of preeclampsia. Clin. Endocrinol. 57:413–423.
   PubMed Web of Science ®Google Scholar
• Panza JA, Epstein SE, Quyyumi AA. (1991). Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N. Engl. J. Med. 325:986–990.
   PubMed Web of Science ®Google Scholar
• Patrono C, Ciabattoni G, Patrignani P, Pugliese F, Filabozzi P, Catella F, Dave G, Forni L. (1985). Clinical pharmacology of platelet cyclo-oxygenase inhibition. Circulation 72:1177–1184.
   PubMed Web of Science ®Google Scholar
• Pinotti M, Bertolucci C, Portaluppi F, Colognesi I, Frigato E, Foa A, Bernardi F. (2005). Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler. Thromb. Vasc. Biol. 25:646–649.
   PubMed Web of Science ®Google Scholar
• Pope JE, Anderson JJ, Felson DT. (1993). A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch. Intern. Med. 153:477–484.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH. (2007). Circadian rhythm and environmental determinants of blood pressure regulation in normal and hypertensive conditions. In White WB (Ed.). Blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa, NJ: Humana Press, 135–158.
   Google Scholar
• Portaluppi F, Smolensky MH. (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652–1667.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Montanari L, Ferlini M, Gilli P. (1990). Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure. Chronobiol. Int. 7:321–327.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R, Bagni B, Pansini R, degli Uberti EC. (1992). Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J. Hypertens. 10:1227–1234.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Cortelli P, Avoni P, Vergnani L, Contin E, Maltoni P, Pavani A, Sforza E, degli Uberti EC, Gambetti P, Lugaresi E. (1994). Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia. Hypertension 23:569–576.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Vergnani L, Manfredini R, Fersini C. (1996). Endocrine mechanisms of blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:113–131.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Boari B, Manfredini R. (2004). Oxidative stress in essential hypertension. Curr. Pharm. Des. 10:1695–1698.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911–1929.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. (2012). Circadian rhythms and cardiovascular health. Sleep Med. Rev. 16:151–166.
   PubMed Web of Science ®Google Scholar
• Redman CW, Bonnar J, Beilin L. (1978). Early platelet consumption in pre-eclampsia. BMJ 1:467–469.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. (2003). Pre-eclampsia, the placenta and the maternal systemic inflammatory response—a review. Placenta 24:s21–s27.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. (2005). Latest advances in understanding preeclampsia. Science 308:1592–1594.
   PubMed Web of Science ®Google Scholar
• Roberge S, Giguère Y, Villa P, Nicolaides K, Vainio M, Forest JC, von Dadelzen P, Vaiman D, Tapp S, Bujold E. (2012a). Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am. J. Perinatol. 29:551–556.
   PubMed Web of Science ®Google Scholar
• Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, Ebrashy A, Bujold E. (2012b). Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn. Ther. 31:141–146.
   PubMed Web of Science ®Google Scholar
• Roberts CL, Algert CS, Morris JM, Ford JB, Henderson-Smart DJ. (2005). Hypertensive disorders in pregnancy: a population-based study. Med. J. Aust. 182:332–335.
   PubMed Web of Science ®Google Scholar
• Roberts CL, Bell JC, Ford JB, Hadfield RM, Algert CS, Morris JM. (2008). The accuracy of reporting of the hypertensive disorders of pregnancy in population health data. Hypertens. Pregnancy 27:285–297.
   PubMed Web of Science ®Google Scholar
• Roberts CL, Ford JB, Algert CS, Antonsen S, Chalmers J, Cnattingius S, Gokhale M, Kotelchuck M, Melve KK, Langridge A, Morris C, Morris JM, Nassar N, Norman JE, Norrie J, Sorensen HT, Walker R, Weir CJ. (2011). Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open 1:e000101.
   PubMed Web of Science ®Google Scholar
• Rotchell YE, Cruickshank JK, Phillips Gay M, Griffiths J, Stewart A, Farrell B, Ayers S, Hennis A, Grant A, Duley L, Collins R. (1998). Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. Br. J. Obstet. Gynaecol. 105:286–292.
   PubMedGoogle Scholar
• Ros HS, Cnattingius S, Lipworth L. (1998). Comparison of risk factors for pre-eclampsia and gestational hypertension in a population-based cohort study. Am. J. Epidemiol. 147:1062–1070.
   PubMed Web of Science ®Google Scholar
• Ruano R, Fontes RS, Zugaib M. (2005). Prevention of preeclampsia with low-dose aspirin—a systematic review and meta-analysis of the main randomized controlled trials. Clinics (Sao Paulo) 60:407–414.
   PubMedGoogle Scholar
• Shennan AH, Kissane J, De Swiet M. (1993). Validation of the SpaceLabs 90207 ambulatory blood pressure monitor for use in pregnancy. Br. J. Obstet. Gynaecol. 100:904–908.
   PubMedGoogle Scholar
• Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, Depp R, and the National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. (1993). Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N. Engl. J. Med. 329:1213–1218.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Caritis S, Hauth J. (2003). What we have learned about preeclampsia. Semin. Perinatol. 27:239–246.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Haus E. (2001). Circadian rhythms in clinical medicine with applications to hypertension. Am. J. Hypertens. 14(9 Pt 2):280S–290S.
   PubMedGoogle Scholar
• Smolensky MH, Portaluppi F. (1999). Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Am. Heart J. 137(4 Pt 2):S14–S24.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. (2007). Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668–680.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press. Monit. 15:173–180.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Siegel RA, Haus E, Hermida R, Portaluppi F. (2012). Biological rhythms, drug delivery, and chronotherapeutics. In Siepmann J, Siegel RA, Rathbone MJ (Eds.). Fundamentals and applications of controlled release drug delivery. Heidelberg, Germany: Springer-Verlag, 359–443.
   Google Scholar
• Snoep JD, Hovens MMC, Pasha SM, Frölich M, Pijl H, Tamsma JT, Huisman MV. (2009). Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines. Hypertension 54:1136–1142.
   PubMed Web of Science ®Google Scholar
• Sothern RB, Vesely DL, Kanabrocki EL, Hermida RC, Bremner FW, Third JLHC, Boles MA, Nemchausky BM, Olwin JH, Scheving LE. (1995). Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure. Chronobiol. Int. 12:106–120.
   PubMed Web of Science ®Google Scholar
• Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. (2010). Pre-eclampsia. Lancet 376:631–644.
   PubMed Web of Science ®Google Scholar
• Svensson A, L Sigström, B Andersch, L Hansson. (1983). Maternal hypertension during pregnancy and high blood pressure in children. Clin. Exp. Hypertens. B Hypertens. Pregnancy 2:203–209.
   PubMed Web of Science ®Google Scholar
• Taubert D, Berkels R, Grosser N, Schroder H, Grundemann D, Schomig E. (2004). Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. Br. J. Pharmacol. 143:159–165.
   PubMed Web of Science ®Google Scholar
• Trasforini G, Margutti A, Portaluppi F, Menegatti M, Ambrosio MR, Bagni B, Pansini R, degli Uberti EC. (1991). Circadian profile of plasma calcitonin gene-related peptide in healthy man. J. Clin. Endocrinol. Metab. 73:945–951.
   PubMed Web of Science ®Google Scholar
• Trivedi NA. (2011). A meta-analysis of low-dose aspirin for prevention of preeclampsia. J. Postgrad. Med. 57:91–95.
   PubMed Web of Science ®Google Scholar
• Varani K, Gessi S, Caiazza A, Rastelli G, Portaluppi F, Borea PA. (1999a). Platelet alpha2-adrenoceptor alterations in patients with essential hypertension. Br. J. Clin. Pharmacol. 47:167–172.
   PubMed Web of Science ®Google Scholar
• Varani K, Portaluppi F, Merighi S, Ongini E, Belardinelli L, Borea PA. (1999b). Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation 99:2499–2502.
   PubMed Web of Science ®Google Scholar
• Varani K, Portaluppi F, Gessi S, Merighi S, Ongini E, Belardinelli L, Borea PA. (2000). Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors: functional and biochemical aspects. Circulation 102:285–289.
   PubMed Web of Science ®Google Scholar
• Walker RL, Hemmelgarn B, Quan H. (2009). Incidence of gestational hypertension in the Calgary Health Region from 1995 to 2004. Can. J. Cardiol. 25:e284–e287.
   PubMed Web of Science ®Google Scholar
• Wallis AB, Saftlas AF, Hsia J, Atrash HK. (2008). Secular trends in the rates of pre-eclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am. J. Hypertens. 21:521–526.
   Web of Science ®Google Scholar
• Walsh SW. (1985). Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am. J. Obstet. Gynecol. 152:335–340.
   PubMed Web of Science ®Google Scholar
• Walsh SW, Wang Y. (1998). Maternal perfusion with low-dose aspirin preferentially inhibits placental thromboxane while sparing prostacyclin. Hypertens. Pregnancy 17:203–215.
   Web of Science ®Google Scholar
• Walsh SW, Wang Y, Kay HH, McCoy MC. (1992). Low-dose aspirin inhibits lipid peroxides and thromboxane but not prostacyclin in pregnant women. Am. J. Obstet. Gynecol. 167:926–930.
   PubMed Web of Science ®Google Scholar
• Wang JL, Cheng HF, Harris RC. (1999). Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension 34:96–101.
   PubMed Web of Science ®Google Scholar
• Willard JE, Lange RA, Hillis LD. (1992). The use of aspirin in ischemic heart disease. N. Engl. J. Med. 327:175–181.
   PubMed Web of Science ®Google Scholar
• Winters CJ, Sallman AL, Vesely DL. (1988). Circadian rhythm of prohormone atrial natriuretic peptides 1–30, 31–67 and 99–126 in man. Chronobiol. Int. 5:403–409.
   PubMed Web of Science ®Google Scholar
• Witte K, Lemmer B. (2003). Rhythms and pharmacodynamics. In Redfern P (Ed.). Chronotherapeutics. London: Pharmaceutical Press, 111–126.
   Google Scholar
• Wu R, Lamontagne D, de Champlain J. (2002). Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation 105:387–392.
   PubMed Web of Science ®Google Scholar
• Wu R, Laplante MA, de Champlain J. (2004). Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J. Hypertens. 22:793–801.
   PubMed Web of Science ®Google Scholar